Boothbay Fund Management’s Lyra Therapeutics LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $29.6K | Hold |
|
|||||
|
2024
Q4 | $48.3K | Buy |
|
|||||
|
2024
Q3 | $59.8K | Hold |
|
|||||
|
2024
Q2 | $64.4K | Hold |
|
|||||
|
2024
Q1 | $1.45M | Sell |
|
|||||
|
2023
Q4 | $1.31M | Buy |
|
|||||
|
2023
Q3 | $915K | Buy |
|
|||||
|
2023
Q2 | $673K | Buy |
|
|||||
|
2023
Q1 | $69.8K | Hold |
|
|||||
|
2022
Q4 | $109K | Hold |
|
|||||
|
2022
Q3 | $174K | Sell |
|
|||||
|
2022
Q2 | $217K | Sell |
|
|||||
|
2022
Q1 | $155K | Hold |
|
|||||
|
2021
Q4 | $168K | Sell |
|
|||||
|
2021
Q3 | $358K | Sell |
|
|||||
|
2021
Q2 | $668K | Sell |
|
|||||
|
2021
Q1 | $970K | Sell |
|
|||||
|
2020
Q4 | $996K | Buy |
|
|||||
|
2020
Q3 | $488K | Buy |
|